Amica Retiree Medical Trust Continues to Hold Position in Ecolab Inc. (ECL)

Amica Retiree Medical Trust held its stake in shares of Ecolab Inc. (NYSE:ECL) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,038 shares of the basic materials company’s stock at the end of the first quarter. Amica Retiree Medical Trust’s holdings in Ecolab were worth $255,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in ECL. JNBA Financial Advisors boosted its stake in shares of Ecolab by 45.5% in the fourth quarter. JNBA Financial Advisors now owns 850 shares of the basic materials company’s stock valued at $100,000 after buying an additional 266 shares in the last quarter. Elgethun Capital Management bought a new stake in shares of Ecolab during the fourth quarter valued at about $117,000. State of Alaska Department of Revenue bought a new stake in shares of Ecolab during the first quarter valued at about $134,000. Perigon Wealth Management LLC boosted its stake in shares of Ecolab by 26.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,262 shares of the basic materials company’s stock valued at $158,000 after buying an additional 262 shares in the last quarter. Finally, Advisory Services Network LLC bought a new stake in shares of Ecolab during the first quarter valued at about $162,000. 75.09% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Ecolab (NYSE:ECL)

Ecolab Inc. (NYSE:ECL) opened at 127.09 on Friday. The stock’s 50 day moving average is $126.38 and its 200 day moving average is $121.67. Ecolab Inc. has a 52 week low of $110.65 and a 52 week high of $129.85. The stock has a market cap of $36.86 billion, a PE ratio of 30.02 and a beta of 0.90.

Ecolab (NYSE:ECL) last released its quarterly earnings data on Tuesday, May 2nd. The basic materials company reported $0.80 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by $0.01. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.16 billion. Ecolab had a return on equity of 19.08% and a net margin of 8.11%. The firm’s revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.77 EPS. Analysts predict that Ecolab Inc. will post $4.78 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 17th. Stockholders of record on Tuesday, June 20th will be paid a $0.37 dividend. The ex-dividend date is Friday, June 16th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.16%. Ecolab’s payout ratio is currently 41.11%.

TRADEMARK VIOLATION WARNING: This piece was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2017/05/20/amica-retiree-medical-trust-continues-to-hold-position-in-ecolab-inc-ecl.html.

Several brokerages recently issued reports on ECL. Canaccord Genuity restated a “buy” rating and issued a $135.00 target price on shares of Ecolab in a report on Monday, May 1st. Nomura upgraded shares of Ecolab from a “reduce” rating to a “neutral” rating and raised their target price for the stock from $99.00 to $118.00 in a report on Monday, April 3rd. Instinet upgraded shares of Ecolab from a “reduce” rating to a “neutral” rating and raised their target price for the stock from $99.00 to $118.00 in a report on Monday, April 3rd. Edward Jones upgraded shares of Ecolab from a “hold” rating to a “buy” rating in a report on Wednesday, February 22nd. Finally, Longbow Research cut shares of Ecolab from a “buy” rating to a “neutral” rating in a report on Wednesday, February 22nd. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and seven have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $127.86.

In other Ecolab news, Director Carl M. Casale acquired 5,000 shares of the business’s stock in a transaction dated Friday, May 5th. The shares were purchased at an average price of $126.33 per share, for a total transaction of $631,650.00. Following the completion of the purchase, the director now directly owns 11,495 shares of the company’s stock, valued at $1,452,163.35. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Christophe Beck sold 6,959 shares of the stock in a transaction on Friday, May 19th. The stock was sold at an average price of $127.11, for a total transaction of $884,558.49. Following the sale, the executive vice president now directly owns 42,419 shares in the company, valued at $5,391,879.09. The disclosure for this sale can be found here. 1.50% of the stock is owned by corporate insiders.

Ecolab Company Profile

Ecolab Inc provides water, hygiene and energy technologies and services. The Company’s cleaning and sanitizing programs and products, pest elimination services and equipment maintenance and repair services support customers in the foodservice, food and beverage processing, hospitality, healthcare, government and education, retail, textile care and commercial facilities management sectors in over 170 countries.

12 Month Chart for NYSE:ECL

Receive News & Ratings for Ecolab Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ecolab Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply